Skip to main content

Advertisement

Log in

Effect of recombinant erythropoietin on ischemia–reperfusion-induced apoptosis in rat liver

  • Original Paper
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

Ischemia–reperfusion (I/R) cannot be avoided in liver transplantation procedures, and apoptosis is a central mechanism of cell death after liver reperfusion. Protective effect of recombinant erythropoietin (rhEPO) on liver apoptosis has not been clearly investigated. This work investigated intraportal (IP) rhEPO-protective effect in a rat model of hepatic I/R-induced apoptosis and its appropriated time and dose of administration. Eight groups were included (n = 10/group): sham-operated, I/R (45 min ischemia and 2 h reperfusion), preconditioned rhEPO I/R (24 h or 30 min before ischemia), and postconditioned rhEPO I/R (before reperfusion) using two different rhEPO doses (1,000 and 5,000 IU/kg). When compared with the sham-operated group, the I/R group showed significant increase of serum levels of aspartate and alanine aminotransferases (AST, ALT), hepatic caspase-9 activity(894.99 ± 176.90 relative fluorescence units (RFU)/mg/min versus 458.48 ± 82.96 RFU/mg/min), and Fas ligand (FasL) expression, histopathological damages, and significant decrease in the antiapoptotic Bcl-xL/apoptotic Bax ratio(0.38 ± 0.21 versus 3.35 ± 0.77) rhEPO-improved ALT and AST but failed to reduce FasL expression in all groups compared with the I/R group. Thirty minutes and 24 h preconditioning with rhEPO (1,000 IU/kg) increased Bcl-xL/Bax ratio and reduced caspase-9 activity, and the same effect was observed when higher dose was given 24 h before ischemia. Preconditioning was more effective than postconditioning in improving caspase-9 activity, and no dose-dependent effect was observed. In conclusion, single IP rhEPO injection 30 min before ischemia has an advantage over rhEPO postconditioning in improving post-hepatic I/R-induced apoptosis with no additional time- and dose-dependent effects which may provide potentially useful guide in liver transplantation procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR (2003) Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biology 5:647–654

    Article  CAS  Google Scholar 

  2. Bramey T, Freitag P, Fandrey J, Rauen U, Pamp K, Erhard J, Frede J, Groot H, Petrat F (2009) No evidence for protective erythropoietin alpha signalling in rat hepatocytes. BMC Gastroenterol 9:26

    Article  PubMed  Google Scholar 

  3. Brines M, Cerami A (2006) Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 70:246–250

    Article  PubMed  CAS  Google Scholar 

  4. Cai Z, Manalo DJ, Wei G (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia–reperfusion injury. Circulation 108:79–85

    Article  PubMed  CAS  Google Scholar 

  5. Chattopadhyay P, Verma N, Verma A, Kamboj T, Ali Khan N, Wahi AK (2008) l-arginine protects from pringle maneuver of ischemia–reperfusion induced liver injury. Biol Pharm Bull 31:890

    Article  PubMed  CAS  Google Scholar 

  6. Chomkczynski P, Sacchi N (1987) Single step method for RNA isolation by the acid guanidinum thiocyanate–phenol–chloroform method. Anal Biochem 162:156–160

    Google Scholar 

  7. Doi Y, Hamazaki K, Yabuki M, Tanaka N, Utsumi K (2001) Effect of HSP70 induced by warm ischemia to the liver on liver function after partial heap. Hepatogast-Roenterology 48:533–540

    CAS  Google Scholar 

  8. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495–505

    PubMed  CAS  Google Scholar 

  9. Fesik SW, Shi Y (2001) Controlling the caspases. Science 294(5546):1477–1478

    Article  PubMed  CAS  Google Scholar 

  10. Friedrich D, Kirsten E, Achim K, Stefanie W, Arno S, Nina R, Patrick E, Philipp D, Alexandra KK, Oliver K, Theodor J (2007) Protection from hepatic ischemia reperfusion injury and improvement of liver regeneration injury and impairment of liver regeneration by lipoic acid. Shock 27:644–651

    Google Scholar 

  11. Ghezzi P, Brines M (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11:S37–S44

    Article  PubMed  CAS  Google Scholar 

  12. Greif F, Ben-Ari Z, Taya R, Pappo O, Kurtzwald E, Cheporko Y, Ravid A, Hochhauser E (2010) Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats. Liver Transpl 16(5):631–638

    PubMed  Google Scholar 

  13. Gujral JS, Bucci TJ, Farhood A, Jaeschke H (2001) Mechanism of cell death during warm hepatic ischemia–reperfusion in rats: apoptosis or necrosis? Hepatol 33:397–405

    Article  CAS  Google Scholar 

  14. Hartkorn A, Hoffmann F, Ajamieh H, Vogel S, Heilmann J, Gerbes AL, Vollmar AM, Zahler S (2009) Antioxidant effects of xanthohumol and functional impact on hepatic ischemia reperfusion injury. J Nat Prod 72:1741–1747

    Article  PubMed  CAS  Google Scholar 

  15. Hauet T, Mothes D, Goujon JM (1997) Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischaemia. Transplantation 64:1082–1086

    Article  PubMed  CAS  Google Scholar 

  16. Hochhauser E, Pappo O, Ribakovsky E, Ravid A, Kurtzwald E, Cheporko Y, Lelchuk S, Ben-Ari Z (2008) Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. Apoptosis 13:77–86

    Article  PubMed  CAS  Google Scholar 

  17. Hu G, Lü X (2005) Effect of normothermic liver ischemic preconditioning on the expression of apoptosis-regulating genes C-jun and Bcl-xL in rats. World J Gastroenterol 11:2579–2582

    PubMed  CAS  Google Scholar 

  18. Jaeschke H (2000) Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15:718

    Article  PubMed  CAS  Google Scholar 

  19. Klemm K, Eipel C, Cantré D, Abshagen K, Menger MD, Vollmar B (2008) Multiple doses of erythropoietin impair liver regeneration by increasing TNF-α, the Bax to Bcl-xL ratio and apoptotic cell death. PLoS ONE 3:3924

    Article  Google Scholar 

  20. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513–519

    Article  PubMed  CAS  Google Scholar 

  21. Lipsic E, Schoemaker RG, van der Meer PVoors AA, van Veldhuisen DJ, van Gilst WH (2006) Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol 48:2161–2167

    Article  PubMed  CAS  Google Scholar 

  22. Nakajima H, Mizuta N, Fujiwara I, Sakaguchi K, Ogata H, Magae J, Yagita H, Koji T (2008) Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia–reperfusion rat liver. Apoptosis 13:1013–1021

    Article  PubMed  CAS  Google Scholar 

  23. Oh K-W, Currin RT, Lemasters JJ (2000) Kupffer cells mediate increased anoxic hepatocellular killing from hyperosmolarity by an oxygen- and prostaglandin-independent mechanism. Toxicol Lett 117:95–100

    Article  PubMed  CAS  Google Scholar 

  24. Schmeding M, Hunold G, Ariyakhagorn V, Rademacher S, Boas-Knoop S, Lippert S, Neuhaus P, Neumann UP (2009) Erythropoietin reduces ischemia–reperfusion injury after liver transplantation in rats. Transpl Int 22:738–746

    Article  PubMed  CAS  Google Scholar 

  25. Schmeding M, Neumann UP, Boas-Knoop S, Spinelli A, Neuhaus P (2007) Erythropoietin reduces ischemia–reperfusion injury in the rat liver. Eur Surg Res 39:189–197

    Article  PubMed  CAS  Google Scholar 

  26. Schmeding M, Neumann UP, Boas-Knoop S, Spinelli A, Neuhaus P (2007) Erythropoietin reduces ischemia–reperfusion injury in the rat liver. Eur Surg Res Clin Exp Surg 39:189–197

    CAS  Google Scholar 

  27. Sepodes B, Maio R, Pinto R, Sharples E, Oliveira P, Mconald M, Yaqoob M, Thiemermann C, Mota-Filipe H (2006) Recombinant human erythropoietin protects the liver from hepatic ischemia reperfusion injury in the rat. Trans Int J 19:919–926

    Article  CAS  Google Scholar 

  28. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G (2004) Erythropoietin protects against ischemic acute renal injury. Nephrol Dial Transplant 19:348–355

    Article  PubMed  CAS  Google Scholar 

  29. Yilmaz S, Ates E, Tokyol C, Pehlivan T, Erkasap S, Koken T (2004) The protective effect of erythropoietin on ischemia/reperfusion injury of liver HPB 6:169–173

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heba M. Shawky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shawky, H.M., Younan, S.M., Rashed, L.A. et al. Effect of recombinant erythropoietin on ischemia–reperfusion-induced apoptosis in rat liver. J Physiol Biochem 68, 19–28 (2012). https://doi.org/10.1007/s13105-011-0114-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-011-0114-2

Keywords

Navigation